Qiagen N.V. (QIA) - Product Pipeline Analysis

Qiagen N.V. (QIA) - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide88 Pages Price :
$ 750

Qiagen N.V. (Qiagen) is a healthcare company providing sample and assay technologies. Through its sample technologies, the company isolates and processes proteins, DNA and RNA from biological samples such as blood or tissue; and through assay technologies, it develops isolated biomolecules, such as the DNA of a specific virus used for subsequent analysis. The company has over 500 products that include consumable products, automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification, as well as open and target specific assays. Qiagen also supplies diagnostic test kits and assays for human and veterinary molecular diagnostics. The company operates in more than 100 countries and sells its products to pharmaceutical and biotechnology companies and research institutions. Qiagen is headquartered in Venlo, the Netherlands.

Qiagen is keen on enhancing its operations through strategic acquisitions. In line with this strategy, it recently completed the acquisition of AmniSure International LLC and Cellestis Limited.

This report is a source for data, analysis and actionable intelligence on the Qiagen N.V. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 5
List of Figures 7

Qiagen N.V. - Business Description 8

Key Facts 10
Qiagen N.V. - Major Products and Services 11
Qiagen N.V. Pipeline Products by Equipment Type 14
Qiagen N.V. Pipeline Products by Development Stage 17
Qiagen N.V. Pipeline Products by Therapy Area 20
Qiagen N.V. Pipeline Products by Trial Phase 23
Qiagen N.V. Pipeline Products by Milestone Summary 25
ABL Assay 27
ABL Assay Product Status 27
ABL Assay Product Description 27
ABL Assay Product Patent Details 28
Artus CT/NG Assay 29
Artus CT/NG Assay Product Status 29
Artus CT/NG Assay Product Description 29
Artus EBV RG 6000 Assay 30
Artus EBV RG 6000 Assay Product Status 30
Artus EBV RG 6000 Assay Product Description 30
Artus EBV RG 6000 Assay Clinical Trial 30
Artus RG PCR CMV Assay 33
Artus RG PCR CMV Assay Product Status 33
Artus RG PCR CMV Assay Product Description 33
Companion Diagnostic Test - ALK Gene 34
Companion Diagnostic Test - ALK Gene Product Status 34
Companion Diagnostic Test - ALK Gene Product Description 34
Companion Diagnostic Test - IDH1/IDH2 Gene 35
Companion Diagnostic Test - IDH1/IDH2 Gene Product Status 35
Companion Diagnostic Test - IDH1/IDH2 Gene Product Description 35
Diagnostic Test - Latent Tuberculosis 36
Diagnostic Test - Latent Tuberculosis Product Status 36
Diagnostic Test - Latent Tuberculosis Product Description 36
Product Institution Details 36
EGFR vIII Assay - Glioblastoma 37
EGFR vIII Assay - Glioblastoma Product Status 37
EGFR vIII Assay - Glioblastoma Product Description 37
EGFR vIII Assay - Glioblastoma Clinical Trial 37
mSept9 Colorectal Cancer Test 40
mSept9 Colorectal Cancer Test Product Status 40
mSept9 Colorectal Cancer Test Product Description 40
NextGen HPV Screening 41
NextGen HPV Screening Product Status 41
NextGen HPV Screening Product Description 41
NextGen HPV Screening Clinical Trial 41
NextGen HPV Screening Product Patent Details 42
PI3K Biomarker Test - Breast Cancer 46
PI3K Biomarker Test - Breast Cancer Product Status 46
PI3K Biomarker Test - Breast Cancer Product Description 46
PI3K Biomarker Test - Lung 47
PI3K Biomarker Test - Lung Product Status 47
PI3K Biomarker Test - Lung Product Description 47
QIAensemble 48
QIAensemble Product Status 48
QIAensemble Product Description 48
QIAensemble 3000+ System With HPV And CT/GC 49
QIAensemble 3000+ System With HPV And CT/GC Product Status 49
QIAensemble 3000+ System With HPV And CT/GC Product Description 49
QIAensemble 3000+ System With HPV And CT/GC Product Patent Details 49
QIAensemble 400 With Screening/Genotyping 53
QIAensemble 400 With Screening/Genotyping Product Status 53
QIAensemble 400 With Screening/Genotyping Product Description 53
QIAensemble JE2000 54
QIAensemble JE2000 Product Status 54
QIAensemble JE2000 Product Description 54
QIAensemble JE800 55
QIAensemble JE800 Product Status 55
QIAensemble JE800 Product Description 55
QIAensemble SP/2000 With Screening And Genotyping 56
QIAensemble SP/2000 With Screening And Genotyping Product Status 56
QIAensemble SP/2000 With Screening And Genotyping Product Description 56
QIAsymphony RGQ - Artus HBV Test 57
QIAsymphony RGQ - Artus HBV Test Product Status 57
QIAsymphony RGQ - Artus HBV Test Product Description 57
QIAsymphony RGQ - Artus HCV Test 58
QIAsymphony RGQ - Artus HCV Test Product Status 58
QIAsymphony RGQ - Artus HCV Test Product Description 58
QIAsymphony RGQ - Artus HHV-6 Test 59
QIAsymphony RGQ - Artus HHV-6 Test Product Status 59
QIAsymphony RGQ - Artus HHV-6 Test Product Description 59
QIAsymphony RGQ - Artus HIV Test 60
QIAsymphony RGQ - Artus HIV Test Product Status 60
QIAsymphony RGQ - Artus HIV Test Product Description 60
QIAsymphony RGQ - Artus JCV Test 61
QIAsymphony RGQ - Artus JCV Test Product Status 61
QIAsymphony RGQ - Artus JCV Test Product Description 61
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit 62
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit Product Status 62
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit Product Description 62
ResPlex II 63
ResPlex II Product Status 63
ResPlex II Product Description 63
ResPlex II Clinical Trial 63
Rotor-Gene Q - Therascreen BCR-ABL RGQ PCR Kit 66
Rotor-Gene Q - Therascreen BCR-ABL RGQ PCR Kit Product Status 66
Rotor-Gene Q - Therascreen BCR-ABL RGQ PCR Kit Product Description 66
Therascreen BRAF RGQ PCR Kit 67
Therascreen BRAF RGQ PCR Kit Product Status 67
Therascreen BRAF RGQ PCR Kit Product Description 67
Therascreen EGFR Assay - Tomtovok 68
Therascreen EGFR Assay - Tomtovok Product Status 68
Therascreen EGFR Assay - Tomtovok Product Description 68
Therascreen EGFR Assay - Tomtovok Clinical Trial 68
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer 70
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer Product Status 70
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer Product Description 70
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer Product Milestone 70
Therascreen KRAS Assay - Dacomitinib 71
Therascreen KRAS Assay - Dacomitinib Product Status 71
Therascreen KRAS Assay - Dacomitinib Product Description 71
Therascreen KRAS RGQ PCR Kit - Panitumumab 72
Therascreen KRAS RGQ PCR Kit - Panitumumab Product Status 72
Therascreen KRAS RGQ PCR Kit - Panitumumab Product Description 72
Therascreen PI3K RGQ PCR Kit 73
Therascreen PI3K RGQ PCR Kit Product Status 73
Therascreen PI3K RGQ PCR Kit Product Description 73
Qiagen N.V. - Key Competitors 74
Qiagen N.V. - Key Employees 75
Qiagen N.V. - Key Employee Biographies 76
Qiagen N.V. - Locations And Subsidiaries 77
Head Office 77
Other Locations & Subsidiaries 77
Recent Developments 79
Qiagen N.V., Recent Developments 79
Jul 24, 2012: Qiagen Reports Revenue Of $307.2m In Q2 2012 79
Apr 25, 2012: QIAGEN Reports Revenue Of $296.4m In Q1 2012 80
Mar 15, 2012: QIAGEN Welcomes US Guideline Changes To Recommend HPV Testing As Part Of Cervical Cancer Screening 80
Jan 31, 2012: Qiagen Reports Revenue Of $1.2 Billion In 2011 81
Jan 06, 2012: QIAGEN Launches QIAensemble Decapper Sample Preparation Automation System 82
Nov 28, 2011: QIAGEN Launches Project To Improve Efficiency And Resource Allocation 82
Nov 02, 2011: Qiagen Reports Revenue Of $288.9m In Q3 2011 83
Aug 08, 2011: QIAGEN Opens Taiwan Subsidiary To Further Expand Presence In Asia 84
Jul 25, 2011: Qiagen Reports Net Sales Of $282.2m In Q2 2011 84
May 06, 2011: QIAGEN Reaches Milestone With 75 Million Deliveries Of HPV Tests, Announces Strategy Update For QIAensemble Program 85

Appendix 88
Methodology 88
About GlobalData 88
Contact Us 88
Disclaimer 88

List of Table


Qiagen N.V., Key Facts 1
Qiagen N.V. Key Pipeline Products by Equipment Type 1
Qiagen N.V. Key Pipeline Products by Therapy Area 1
Qiagen N.V. Key Pipeline Products by Development Stage 1
Qiagen N.V. Key Pipeline Products by Trial Phase 1
Qiagen N.V., Key Facts 10
Qiagen N.V., Major Products and Services 11
Qiagen N.V. Number of Pipeline Products by Equipment Type 14
Qiagen N.V. Pipeline Products by Equipment Type 15
Qiagen N.V. Number of Pipeline Products by Development Stage 17
Qiagen N.V. Pipeline Products by Development Stage 18
Qiagen N.V. Number of Pipeline Products by Therapy Area 20
Qiagen N.V. Pipeline Products by Therapy Area 21
Qiagen N.V. Number of Pipeline Products by Trial Phase 23
Qiagen N.V. Pipeline Products by Trial Phase 24
Qiagen N.V. Number of Pipeline Products By Milestone Summary 25
Qiagen N.V. Pipeline Products by Milestone Summary 26
ABL Assay - Product Status 27
ABL Assay - Product Description 27
ABL Assay - Patent Details1 28
ABL Assay - Patent Details2 28
Artus CT/NG Assay - Product Status 29
Artus CT/NG Assay - Product Description 29
Artus EBV RG 6000 Assay - Product Status 30
Artus EBV RG 6000 Assay - Product Description 30
Artus EBV RG 6000 Assay - Validation Of An Epstein-Barr Viral Load Assay Using The QIAGEN Artus EBV Pcr Analyte-Specific Reagent 30
Artus RG PCR CMV Assay - Product Status 33
Artus RG PCR CMV Assay - Product Description 33
Companion Diagnostic Test - ALK Gene - Product Status 34
Companion Diagnostic Test - ALK Gene - Product Description 34
Companion Diagnostic Test - IDH1/IDH2 Gene - Product Status 35
Companion Diagnostic Test - IDH1/IDH2 Gene - Product Description 35
Diagnostic Test - Latent Tuberculosis - Product Status 36
Diagnostic Test - Latent Tuberculosis - Product Description 36
EGFR vIII Assay - Glioblastoma - Product Status 37
EGFR vIII Assay - Glioblastoma - Product Description 37
EGFR vIII Assay - Glioblastoma - Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy 37
mSept9 Colorectal Cancer Test - Product Status 40
mSept9 Colorectal Cancer Test - Product Description 40
NextGen HPV Screening - Product Status 41
NextGen HPV Screening - Product Description 41
NextGen HPV Screening - The Next-generation Hybrid Capture High-Risk HPV DNA Assay on a Fully Automated Platform 41
NextGen HPV Screening - Patent Details1 42
NextGen HPV Screening - Patent Details2 43
NextGen HPV Screening - Patent Details3 43
NextGen HPV Screening - Patent Details4 44
NextGen HPV Screening - Patent Details5 44
NextGen HPV Screening - Patent Details6 45
PI3K Biomarker Test - Breast Cancer - Product Status 46
PI3K Biomarker Test - Breast Cancer - Product Description 46
PI3K Biomarker Test - Lung - Product Status 47
PI3K Biomarker Test - Lung - Product Description 47
QIAensemble - Product Status 48
QIAensemble - Product Description 48
QIAensemble 3000+ System With HPV And CT/GC - Product Status 49
QIAensemble 3000+ System With HPV And CT/GC - Product Description 49
QIAensemble 3000+ System With HPV And CT/GC - Patent Details1 49
QIAensemble 3000+ System With HPV And CT/GC - Patent Details2 50
QIAensemble 3000+ System With HPV And CT/GC - Patent Details3 50
QIAensemble 3000+ System With HPV And CT/GC - Patent Details4 51
QIAensemble 3000+ System With HPV And CT/GC - Patent Details5 51
QIAensemble 3000+ System With HPV And CT/GC - Patent Details6 52
QIAensemble 400 With Screening/Genotyping - Product Status 53
QIAensemble 400 With Screening/Genotyping - Product Description 53
QIAensemble JE2000 - Product Status 54
QIAensemble JE2000 - Product Description 54
QIAensemble JE800 - Product Status 55
QIAensemble JE800 - Product Description 55
QIAensemble SP/2000 With Screening And Genotyping - Product Status 56
QIAensemble SP/2000 With Screening And Genotyping - Product Description 56
QIAsymphony RGQ - Artus HBV Test - Product Status 57
QIAsymphony RGQ - Artus HBV Test - Product Description 57
QIAsymphony RGQ - Artus HCV Test - Product Status 58
QIAsymphony RGQ - Artus HCV Test - Product Description 58
QIAsymphony RGQ - Artus HHV-6 Test - Product Status 59
QIAsymphony RGQ - Artus HHV-6 Test - Product Description 59
QIAsymphony RGQ - Artus HIV Test - Product Status 60
QIAsymphony RGQ - Artus HIV Test - Product Description 60
QIAsymphony RGQ - Artus JCV Test - Product Status 61
QIAsymphony RGQ - Artus JCV Test - Product Description 61
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit - Product Status 62
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit - Product Description 62
ResPlex II - Product Status 63
ResPlex II - Product Description 63
ResPlex II - Evaluation Of Commercial Resplex II V2.0, Multicode-Plx, And Xtag Respiratory Viral Panels For The Diagnosis Of Respiratory Viral Infections In Adults 63
ResPlex II - Differential Detection Of 19 Respiratory Viruses Including The New Influenza A Strain H1N1 2009 With The Resplex II Plus Panel 64
Rotor-Gene Q - Therascreen BCR-ABL RGQ PCR Kit - Product Status 66
Rotor-Gene Q - Therascreen BCR-ABL RGQ PCR Kit - Product Description 66
Therascreen BRAF RGQ PCR Kit - Product Status 67
Therascreen BRAF RGQ PCR Kit - Product Description 67
Therascreen EGFR Assay - Tomtovok - Product Status 68
Therascreen EGFR Assay - Tomtovok - Product Description 68
Therascreen EGFR Assay - Tomtovok - Efficacy Study Of EGFR PCR Assay For Lung Cancer 68
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer - Product Status 70
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer - Product Description 70
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer - Product Milestone 70
Therascreen KRAS Assay - Dacomitinib - Product Status 71
Therascreen KRAS Assay - Dacomitinib - Product Description 71
Therascreen KRAS RGQ PCR Kit - Panitumumab - Product Status 72
Therascreen KRAS RGQ PCR Kit - Panitumumab - Product Description 72
Therascreen PI3K RGQ PCR Kit - Product Status 73
Therascreen PI3K RGQ PCR Kit - Product Description 73
Qiagen N.V., Key Employees 75
Qiagen N.V., Key Employee Biographies 76
Qiagen N.V., Subsidiaries 77

List of Chart


Qiagen N.V. Key Pipeline Products by Equipment Type 1
Qiagen N.V. Pipeline Products by Equipment Type 14
Qiagen N.V. Pipeline Products by Development Stage 17
Qiagen N.V. Pipeline Products by Therapy Area 20
Qiagen N.V. Pipeline Products by Trial Phase 23
Qiagen N.V. Pipeline Products by Milestone Summary 25

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top